Inventors:
Kenneth Eli Morgenstern - Wayne PA, US
International Classification:
A61K 51/00, A61M 36/14, A61K 31/00, A61K 38/00, A61K 47/00, A01N 61/00, A61P 9/10, A61P 27/02
US Classification:
424 111, 514 1, 514 12, 514 208
Abstract:
The invention is directed to a method for preventing nasolacrimal duct obstruction (NLDO) in a patient receiving high dose radioactive iodine for treatment of cancer. The method includes administering an effective amount of perchlorate anion to the eyes of the patient.